HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Refocusing Olay Innovation As Brand Revival Continues

This article was originally published in The Rose Sheet

Executive Summary

P&G leadership discussed the firm’s ongoing efforts to reinvigorate Olay, the only major brand in its skin and personal-care segment that has not grown over the past four years, during a Nov. 18 Analyst Day presentation.

You may also be interested in...



P&G's Grooming Biz Takes Hit In Q3; Beauty 'Continually Improving'

Procter & Gamble’s third-quarter results suffered from 6% and 2% declines in grooming and beauty, respectively, attributed largely to increased competition and a global slowdown in consumer spending.

P&G Health Care Outshines Other Segments In Q2, Driving Organic Gains

Firm’s Health Care segment advanced 5% (7% organically) in the second quarter on the strength of innovations in oral care and personal health. Beauty and Grooming were less impactful, but the firm’s overall organic growth of 2% surpassed analyst expectations.

Baxter Of California Launches ‘WTF’ Video Series To Millennial Set

L’Oreal brand’s videos, launching at a rate of one each week, are reminiscent of other humorous campaigns that have made waves in the men’s grooming segment, featuring wisecracking celebs, raffishly dropped f-bombs and readily digestible grooming pointers. Baxter head Nathan Puksta discusses the initiative, Baxter’s approach to the category and the brand’s plans going forward.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel